VUF11207 fumarate (b)

CAS No. 1378524-41-4

VUF11207 fumarate (b)( VUF-11207 | VUF 11207 )

Catalog No. M11561 CAS No. 1378524-41-4

A potent CXCR7 (ACKR3) agonist with EC50 of 1.6 nM; inducse recruitment of β-arrestin2 and subsequent internalization of CXCR7 in cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    VUF11207 fumarate (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent CXCR7 (ACKR3) agonist with EC50 of 1.6 nM; inducse recruitment of β-arrestin2 and subsequent internalization of CXCR7 in cells.
  • Description
    A potent CXCR7 (ACKR3) agonist with EC50 of 1.6 nM; inducse recruitment of β-arrestin2 and subsequent internalization of CXCR7 in cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    VUF-11207 | VUF 11207
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1378524-41-4
  • Formula Weight
    586.66
  • Molecular Formula
    C31H39FN2O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(=CC1=CC=CC=C1F)CN(CCC2CCCN2C)C(=O)C3=CC(=C(C(=C3)OC)OC)OC
  • Chemical Name
    N-[(2E)-3-(2-Fluorophenyl)-2-methyl-2-propen-1-yl]-3,4,5-trimethoxy-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]benzamide fumarate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wijtmans M, et al. Eur J Med Chem. 2012 May;51:184-92.
molnova catalog
related products
  • (S)-CCX-777

    A small-molecule partial agonist of CXCR7 (ACKR3).

  • AZ 13381758

    A potent, small molecule CXCR2 inhibitor with IC50 of 26 nM and 30 nM for mCXCR2 and hCXCR2, respectively.

  • Danirixin

    Danirixin (GSK-1325756) is a high-affinity, selective and reversible CXCR2 antagonist (IC50=12.5 nM, CXCL8).